Question Bank › The feared thing keeps not happening

The feared thing keeps not happening

The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i

Calls Tested
994
Answered YES
93
Hit Rate
9.4%
rare by design

Sensata Technologies Holding plc (ST) — this company's answers

NO on the Q2 2017 call 2017-07-25 B+
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断是否存在一个具体的、公司特定的负面担忧,并且管理层用已经观察到的业务证据来反驳这一担忧。 首先,寻找担忧。在电话会议中,分析师和公司管理层多次提到一些担忧。例如,关于汽车产量放缓、柴油发动机市场份额下降、中国汽车市场可能疲软等。但我们需要找到一个具体的、公司特定的担忧,并且管理层用实际数据反驳。 在问答环节,分析师Wamsi Mohan问及中国汽车市场第二季度后的疲软,以及工业/暖通空调市场的增长是否可持续。Martha Sullivan回应说,预期与之前指导一致,内容增长持续。这似乎是对担忧的回应,但担忧是“中国汽车市场可能疲软”,而管理层说预期一致,没有具体反驳。 另一个担忧是关于柴油发动机市场份额下降。分析师Shawn Harrison提到柴油市场份额下降,但Martha Sullivan说柴油渗透率下降已持续五年,但公司欧洲业务仍增长,并强调内容增长抵消了影响。这似乎是用历史数据反驳,但担忧是具体的吗?分析师提到“柴油市场占有率下降”,这是行业趋势,但公司说影响被抵消。这算不算公司特定担忧?可能算,但管理层没有提供具体当前数据,而是说“你看到的是我们欧洲业务增长”,但未给出具体数字。 更明显的担忧是关于汽车产量下降。分析师多次问及汽车产量,但管理层说公司通过内容增长跑赢市场。例如,Martha Sullivan说“我们的汽车业务在第二季度跑赢了疲软的汽车生产市场,得益于良好的内容增长。”这算是对担忧的回应,但担忧是“汽车产量下降”,而公司说内容增长抵消了。这算具体担忧吗?可能。 但我们需要一个“具体的、公司特定的恐惧”,并且管理层用“已经观察到的行为”反驳。在电话会议中,有一个明显的担忧是“汽车产量下降会影响公司收入”,但公司用实际数据反驳:第二季度汽车业务有机增长1.4%,尽管产量下降。这算吗?但担忧是宏观的,不是公司特定的。 另一个担忧是“中国汽车市场可能疲软”,但公司说内容增长持续。 再仔细看,分析师Wamsi Mohan问:“中国是优势,但第二季度后中国汽车市场可能疲软,你预期工业/暖通空调市场的强劲会持续吗?”管理层回答:“我们预期与之前指导一致,内容增长持续。”这没有具体反驳。 另一个担忧是“柴油发动机市场份额下降”,但公司说影响被抵消。 或许有一个更具体的担忧:关于“汽车产量下降”导致公司收入增长放缓。但公司用实际数据反驳:第二季度有机增长3.6%,汽车业务增长1.4%跑赢市场。这算吗? 但我们需要一个“公司特定的恐惧”,比如“担心失去某个大客户”或“担心新产品失败”等。在电话会议中,没有明显这样的担忧。 或许担忧是“公司能否在汽车产量放缓时保持盈利增长”,但管理层用实际数据反驳:第二季度EPS增长12.3%,利润率提升。这算吗? 但担忧是“盈利增长能否持续”,管理层用当前业绩反驳。 然而,问题要求“一个具体的负面结果,投资者、分析师或市场明显担心会发生”,并且“管理层通过指出当前已经观察到的业务证据来反驳”。在电话会议中,分析师多次问及汽车产量、中国、柴油等,但管理层通常说“符合预期”或“内容增长抵消”。没有特别具体的恐惧被命名。 或许有一个担忧是“公司能否实现协同效应”,但管理层说正在实现。 再读一遍,分析师Rich Kwas问:“Q3收入指引略好于预期,但EPS指引略低,似乎利润率更保守,有什么风险?”管理层说不是保守,是正常季节性。这不算。 或许担忧是“公司能否在汽车产量下降时保持增长”,但管理层用实际数据反驳。 但问题要求“公司特定的恐惧”,比如“担心失去某个大客户”或“担心新产品失败”等。在电话会议中,没有明显这样的担忧。 或许担忧是“柴油发动机市场份额下降”是具体的,但那是行业趋势,不是公司特定。 另一个担忧是“中国汽车市场可能疲软”,但那是宏观。 或许担忧是“公司能否实现全年指引”,但管理层说有信心。 我认为没有明确的、公司特定的恐惧被命名。分析师的问题都是关于市场趋势,而不是公司特定风险。 因此,答案应为NO。 但让我们再确认一下。在电话会议中,Martha Sullivan说:“我们继续相信,我们业务中的整体内容增长比终端市场更重要,终端市场不会成为整体增长的主要驱动力,除了HVOR。”这似乎是在回应担忧。 但担忧是什么?分析师没有明确说“我们担心你们会因汽车产量下降而收入下滑”,但隐含了。 然而,问题要求“一个具体的负面结果”,并且“管理层用已经观察到的证据反驳”。在电话会议中,管理层确实用第二季度实际数据反驳了汽车产量下降的担忧,但担忧是宏观的,不是公司特定的。 或许担忧是“公司能否在汽车产量下降时保持盈利增长”,但管理层用实际数据反驳了。 但问题要求“公司特定的恐惧”,比如“担心失去某个大客户”或“担心新产品失败”等。在电话会议中,没有明显这样的担忧。 因此,我认为答案应为NO。 但让我们再仔细看,是否有分析师直接问“你们是否担心X?”没有。 所以,答案NO。

← Back to the full ST analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company — a worry that is live on this call, evident either because analysts keep probing it or because management itself names it as a concern others hold — AND does management push back on that worry by pointing to CURRENT, ALREADY-OBSERVED evidence from the business showing that the feared outcome is, so far, NOT materializing? Answer YES when BOTH halves come through in the transcript as one coherent dynamic, in whatever form fits the business: (1) A NAMED, COMPANY-SPECIFIC FEAR THAT IS LIVE NOW. The worry is concrete and attached to this company — for example: that demand will fall off after an unusually strong stretch; that a major customer, contract, or partner will shrink, leave, or not renew; that a competitor, new technology, or cheaper alternative will take the company's business; that a key product, franchise, or pricing level is about to erode; that recent growth is a one-time bulge that will reverse; or another identifiable adverse outcome the market has been bracing for. The fear must be visible on the call itself — analysts returning to it in their questions, or management acknowledging in its own words that this is what people are worried about — not merely a generic risk factor or ordinary caution. (2) MANAGEMENT ANSWERS WITH OBSERVED BEHAVIOR, NOT REASSURANCE. Management responds by citing things that have ALREADY HAPPENED or are happening now — customers renewing, reordering, or expanding when they were expected to leave; demand holding or growing through the period when a drop-off was predicted; the threatened product, customer, or pricing actually performing in the recent period; competitive losses that have not shown up in real accounts; the feared cliff period arriving and being cleared — described with enough concrete substance (who, what, how much, or compared to when) that the rebuttal rests on evidence from the business rather than on confidence, promises, arguments about why the fear is illogical, or projections that the future will be fine. Answer NO if no specific company-attached worry is visible on the call — a routinely healthy company fielding ordinary questions is not this. Answer NO if the fear is visible but management's response is mainly reassurance, optimism, plans, or forecasts without already-observed evidence against it. Answer NO if the evidence shows the feared outcome IS materializing and management is excusing, minimizing, or promising to fix it. Answer NO if the worry is only broad macro or industry-wide gloom with nothing specific to this company's own business. Answer NO if management concedes the fear is valid and pivots to a different story instead of countering it. Answer NO if the counter-evidence is only a single vague assertion (such as 'demand remains strong') with no concrete grounding in what has actually occurred. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AVTR Avantor, Inc. Q2 2024 2024-07-26 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
GL Globe Life Inc. Q1 2024 2024-04-23 F
MNKD MannKind Corporation Q4 2023 2024-02-27 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
TYGO Tigo Energy, Inc. Q4 2023 2024-02-14 F
MET MetLife, Inc. Q4 2023 2024-02-01 B+
BBVA Banco Bilbao Vizcaya Argentaria, S.A. Q4 2023 2024-01-30 B+
TBLA Taboola.com Ltd. Q3 2023 2023-11-08 B+
GMED Globus Medical, Inc. Q3 2023 2023-11-07 B
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
MAC The Macerich Company Q3 2023 2023-10-31 D
LNTH Lantheus Holdings, Inc. Q2 2023 2023-08-03 C+
SITM SiTime Corporation Q2 2023 2023-08-02 C+
TREX Trex Company, Inc. Q2 2023 2023-07-31 B+
REYN Reynolds Consumer Products Inc. Q1 2023 2023-05-10 C
DOCN DigitalOcean Holdings, Inc. Q1 2023 2023-05-09 C+
ULCC Frontier Group Holdings, Inc. Q1 2023 2023-05-07 C+
AKR Acadia Realty Trust Q4 2022 2023-05-06 B+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
EPR EPR Properties Q1 2023 2023-04-27 C+
MEDP Medpace Holdings, Inc. Q1 2023 2023-04-25 B+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
POOL Pool Corporation Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
REGN Regeneron Pharmaceuticals, Inc. Q4 2022 2023-02-03 C
HBAN Huntington Bancshares Incorporated Q4 2022 2023-01-20 B
A Agilent Technologies, Inc. Q4 2022 2022-11-21 B+
PCTY Paylocity Holding Corporation Q1 2023 2022-11-05 A
TT Trane Technologies plc Q3 2022 2022-11-02 A
APOG Apogee Enterprises, Inc. Q2 2023 2022-09-20 A
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
ZBRA Zebra Technologies Corporation Q2 2022 2022-08-02 C+
LIN Linde plc Q2 2022 2022-07-28 B+
SHW The Sherwin-Williams Company Q2 2022 2022-07-27 D
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
SE Sea Limited Q1 2022 2022-05-17 F
DCGO DocGo Inc. Q1 2022 2022-05-14 C
ZVIA Zevia PBC Q1 2022 2022-05-12 B
EGHT 8x8, Inc. Q4 2022 2022-05-10 C+
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
ABNB Airbnb, Inc. Q1 2022 2022-05-03 B+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
BSX Boston Scientific Corporation Q1 2022 2022-04-27 B
CCK Crown Holdings, Inc. Q1 2022 2022-04-26 C+
FR First Industrial Realty Trust, Inc. Q1 2022 2022-04-21 A
SDIG Stronghold Digital Mining, Inc. Q3 2021 2021-11-30 F
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
HSY The Hershey Company Q3 2021 2021-10-28 C
PEP PepsiCo, Inc. Q3 2021 2021-10-05 B
GDS GDS Holdings Limited Q2 2021 2021-08-17 C+
PTVE Pactiv Evergreen Inc. Q2 2021 2021-08-08 C+
SPG Simon Property Group, Inc. Q2 2021 2021-08-02 B
GLW Corning Incorporated Q2 2021 2021-07-27 B+
DOV Dover Corporation Q2 2021 2021-07-20 B+
VLRS Controladora Vuela Compañía de Aviación, Q2 2021 2021-07-16 B+
MAR Marriott International, Inc. Q2 2018 2018-08-07 B
VALE Vale S.A. Q2 2018 2018-07-26 B
FICO Fair Isaac Corporation Q3 2018 2018-07-26 C+
ORAN Orange SA Q2 2018 2018-07-26 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
TRUE TrueCar, Inc. Q1 2018 2018-05-08 C
TGNA TEGNA Inc. Q1 2018 2018-05-08 B+
CVS CVS Health Corporation Q1 2018 2018-05-02 B+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
MIDD The Middleby Corporation Q4 2017 2018-02-28 C
SBUX Starbucks Corporation Q1 2018 2018-01-26 C
AVT Avnet, Inc. Q2 2018 2018-01-25 B
GURE Gulf Resources, Inc. Q3 2017 2017-11-14 F
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
MKTX MarketAxess Holdings Inc. Q3 2017 2017-10-25 C+
PII Polaris Inc. Q3 2017 2017-10-24 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BCRX BioCryst Pharmaceuticals, Inc. Q1 2017 2017-05-07 B
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
CGNT Cognyte Software Ltd. Q4 2016 2017-03-09 D
BDC Belden Inc. Q4 2016 2017-02-02 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
TGI Triumph Group, Inc. Q2 2017 2016-11-03 C+
SEM Select Medical Holdings Corporation Q1 2016 2016-05-06 C+
LPSN LivePerson, Inc. Q1 2016 2016-05-04 B
UVE Universal Insurance Holdings, Inc. Q1 2016 2016-05-03 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
VRTS Virtus Investment Partners, Inc. Q1 2016 2016-04-29 D
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
BX Blackstone Inc. Q1 2016 2016-04-21 B
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

TGI · Q2 2017 → YESThe question is: Is there a specific negative outcome that investors/analysts/market are worried about for THIS company, live on this call, and does management push back with CURRENT, ALREADY-OBSERVED...YES The specific, company-attached fear that is live on the call is that Triumph will continue to face large performance-related charges, cash burn on development programs, and failure to stabilize margins/cash flow despite the transformation (a worry analysts repeatedly probe via questions on the $80M risk, free-cash-use guidance, 747-8/C-17/G650 headwinds, and red programs). Management directly counters it by citing already-observed evidence: Q2 operating income of $70.
ULCC · Q1 2023 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors/analysts/market have been worried about for THIS company, live on this call, AND does management push back with CURRENT, ALREADY-OB...YES The transcript shows a live, company-specific worry about pilot staffing shortages (tied to network changes and new contracts elsewhere) and customer churn/retention due to lower satisfaction scores. Management directly counters both with current evidence: pilot surplus and attrition on target for staffing, plus over 90% repeat business for retention.
HOLX · Q4 2017 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company, and does management push back on that worry by poin...YES The transcript shows a live, company-specific fear centered on Cynosure: investors and analysts are worried that the acquisition will not deliver sustainable growth, that recent sequential declines reflect a lasting salesforce collapse or competitive erosion, and that the business will continue underperforming expectations rather than turning around.

More from the question bank

Doors opening at the company's own gatesReporting the counterparty's growth as its oSecond proving already underwayNew normal declared and staffedBigger than they can carry aloneDemand arrived first, the company is growingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.